{"id":"W2335069544","doi":"10.1016/j.clcc.2016.03.004","title":"A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cetuximab; Medicine; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Phosphatidylinositol; Kinase; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001067189,0.0004689317,0.001439741,0.0001049408,0.0001036147,0.00002365846,0.0003953003,0.0002873875,0.0001797134],"category_scores_gemma":[0.0006002033,0.0002673388,0.0002653339,0.0003458555,0.00100341,0.00004619634,0.0001616062,0.0002693464,0.00000320358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001440185,"about_ca_system_score_gemma":0.001305154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002563391,"about_ca_topic_score_gemma":0.001505789,"domain_scores_codex":[0.9961292,0.0006879047,0.001129811,0.0009649508,0.0005262724,0.0005618575],"domain_scores_gemma":[0.9977831,0.0003605952,0.0006606814,0.0004497942,0.0004410309,0.0003047686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8902742,0.00341602,0.09481941,0.00004037709,0.0003357078,0.00001979765,0.00008988622,0.0000168407,0.005667215,0.000006254576,0.000275828,0.005038514],"study_design_scores_gemma":[0.8392576,0.05998086,0.003427244,0.0002151759,0.0003768021,0.000003830185,0.00003621081,0.0001092124,0.09556294,0.00001582533,0.00045324,0.0005610786],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958971,0.0002930204,0.000157036,0.00007532283,0.0006864308,0.002572536,0.0002151866,0.00002526009,0.00007814769],"genre_scores_gemma":[0.9974227,0.00007616291,0.001006622,0.0001482259,0.0003663444,0.000652604,0.00008427395,0.000077809,0.0001652711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09139217,"threshold_uncertainty_score":0.9999779,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03115746277251978,"score_gpt":0.3507161003024449,"score_spread":0.3195586375299251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}